Galderma’s Post

As we approach 2025, the Dermasphere is set to embrace an AI-driven future. Here are the top trends and news that every derm marketer should know, as seen in the latest Dermatology.Business newsletter, just out this morning: -> Emotional skin: Recent studies suggest that skin can reflect your emotional state, suggesting new marketing approaches for skincare products -> JAK Inhibitors for TEN: Treating Toxic Epidermal Necrolysis with JAK inhibitors could make a difference for patients with this rare disorder -> Kenvue's earnings provide some insights into the financial health of major players in the derm sector -> FDA's miffed with Merz: US regulators expressed concerns over the company's influencer campaign, highlighting the need for stricter compliance in marketing Stay ahead of the curve by understanding how #AI and each of these key trends will shape the future of derm marketing. Dermatology.Business is created by Chronicle Companies, publishers of The Chronicle of Skin & Allergy and organizer of the Skin Spectrum Summit. 🌲Merry Christmas and a healthy 2025 to everyone in the Dermasphere. https://lnkd.in/g9E-2QqA #purposedrivendermatology #skinhealthforall #andtoallagoodnight

Did you know that your skin, the largest organ in the body, is rich in cannabinoid receptors? These receptors are crucial for maintaining a healthy skin tone through the endocannabinoid system. A growing body of research suggests that cannabinoids hold significant promise in treating various skin conditions, including eczema, psoriasis, acne, pruritus, hair disorders, and even skin cancer. The science behind this is compelling. Cannabinoids interact with the endocannabinoid system in ways that can help modulate skin functions, reduce inflammation, regulate oil production, and support the skin's natural healing processes. This emerging research highlights the potential of cannabinoids as a natural and practical approach to skin health. Studies such as those by Tóth et al. (2019) and Oláh et al. (2014) have shown that cannabinoids can reduce the symptoms of psoriasis and acne, respectively. Moreover, research published by Ramot et al. (2013) indicates the potential for cannabinoids in treating hair disorders. The therapeutic potential of cannabinoids in dermatology is becoming increasingly recognized in the scientific community. As we continue to learn about the full capabilities of the endocannabinoid system, it becomes clear that maintaining its function is not only about overall balance and health but also has a lot to do with preserving and enhancing skin vitality. Embracing cannabinoids could be a critical step toward achieving healthier skin through natural means for many future applications as patients are having success now." -Mike Robinson Founder Nanobles Corp. / Global Cannabinoid Research Center (GCRC) Tóth, K. F., et al. (2019). "Endocannabinoid signaling in the skin." Journal of Dermatological Science, 95(3), 214-220. Oláh, A., et al. (2014). "Cannabidiol exerts sebostatic and anti-inflammatory effects on human sebocytes." Journal of Clinical Investigation, 124(9), 3713-3724. Ramot, Y., et al. (2013). "Endocannabinoid system in skin physiology and pathophysiology." Trends in Pharmacological Sciences, 34(9), 448-457.

We interviewed Dr. Salah Hassan Ibrahim, a specialist in dermatology, who provided detailed insights into common complaints and advice on how to prevent or treat patients visiting the clinics . During the interview, the doctor highlighted that the most common complaints include acne, dry skin, allergies, and skin scars. He specifically pointed out the harmful effects of using skin-bleaching chemicals, which can lead to long-term health complications.

It's Ichthyosis Awareness Month! Please help us educate, raise awareness, bust myths and support! What is ichthyosis? Ichthyosis comprises a group of genetic skin disorders characterised by dry, scaly skin. It arises from a deficiency in proteins essential for skin maintenance, leading to abnormal shedding and thickening of the skin's outer layer. Symptoms range from mild dryness to severe scaling, impacting physical and emotional well-being. #IAM204 #ichthyosisawareness #ichthyosis #skinconditions #research #skin Fontus Health Ltd.Quoin Pharmaceuticals Mölnlycke Health Care Thornton & Ross Alliance Pharmaceuticals Limited GlobalSkin - International Alliance of Dermatology Patient Organizations Beiersdorf Ego Pharmaceuticals UK L'Oréal

Dermatology is frequently perceived as a minor, superficial discipline, but the reality is quite the opposite! Skin diseases are a highly relevant cause of health loss globally in terms of:   📈 Prevalence: One third of the population suffers from at least one skin condition – the number of new cases per year of psoriasis, atopic dermatitis and melanoma have doubled during the past decades! 📌  Burden of disease: The 15 most common and researched skin conditions combined are the fourth leading cause of non-fatal disease burden at the global level. 🛏 Quality of life: Chronic skin diseases impair patients' quality of life more drastically than asthma, epilepsy or diabetes! 💰 Costs: Skin diseases in the US incur direct healthcare expenses of $75 billion, with an additional $11 billion in lost opportunity costs. Given that these figures are from 2013, current estimates suggest even higher costs today. At Dermagnostix, we are a dedicated group of dermatologists, researchers, engineers, biologists and skin enthusiasts from many more disciplines committed to improving care for patients suffering from skin diseases!

Poikiloderma is a challenging condition, but it’s possible to achieve remarkable outcomes with the right approach. 🌟 Did you know winter is the best time to treat poikiloderma? Patients can minimize further damage and achieve optimal results by addressing it before the summer months. In this article, I share evidence-based strategies for managing this condition effectively, focusing on personalized care and innovative treatments. Let’s continue raising the bar in dermatology! https://lnkd.in/eCFUU6VN #DermatologyCare #SkinHealth #PoikilodermaTreatment #InnovativeDermatology #WinterSkinCare"

If you’re experiencing persistent dryness, soreness or irritation of your lips, you may be dealing with a condition known as "cheilitis." This common concern presents with symptoms such as: ➡️ Dry, cracked, or peeling lips ➡️ Persistent soreness or redness around the mouth ➡️ Irritated or swollen lips ➡️ Pain or discomfort while eating or talking. Cheilitis can be triggered by a variety of factors such as genetic/atopic tendencies, medications, allergies to lip balms or dental products, and lip-licking habits.  But don't worry! Our team of Specialist Dermatologists at Southern Dermatology is here to help! If you are struggling to get on top of cheilitis, book a consultation with us to receive an accurate diagnosis and an effective management plan. We are committed to helping you find relief and get you back to feeling comfortable and confident. Stay tuned for more information on cheilitis and things you can do to avoid it! 👀 #CheilitisCare #LipHealth #SouthernDermatology #DermatologyExperts #MelbourneDermatology #DrRyanDeCruz

Is Nino Nana the right choice for sensitive skin? Absolutely! 🌟 We’re proud to have earned the prestigious Excellent mark from Dermatest® (Germany)—a leading independent dermatology institute trusted since 1978. This seal of approval means our diapers are safe even for the most sensitive skin, backed by rigorous clinical testing. 🔎 How we ensure safety and quality: Comprehensive Testing: Dermatest executes customized studies for each product to ensure thorough evaluations. Ingredient Risk Analysis: All ingredients are meticulously assessed to guarantee safety before any tests begin. Clinical Study: A mix of in vivo and in vitro methods are used to evaluate product performance, ensuring reliable, real-world results. Certified Seal of Excellence: If the product meets Dermatest’s high standards, it is awarded the Dermatest seal—an internationally recognized mark of quality. This certification isn’t just a badge—it’s a reflection of our commitment to providing diapers that are truly skin-friendly, backed by science, and trusted by experts. At Nino Nana, our promise is more than just words—it's verified. ✅ Discover more about our certifications and how we’re raising the bar for baby care: https://lnkd.in/g3acW2Wf

🩺 Follow-Up Post: Adapting Acne Treatment for Better Outcomes 🔄 Adjusting the Approach: A Journey in Acne Management In the ever-evolving world of clinical dermatology, one key lesson stands out: flexibility is critical. I recently shared a case of a patient struggling with moderate-to-severe inflammatory acne that was compounded by lifestyle factors like stress and sleep. Despite his sleep situation mild improving and starting treatment with fusidic acid and azelaic acid, the progress over 1 weeks was suboptimal and not satisfactory. This prompted me to reassess and refine the treatment plan. 💡 The New Approach After careful evaluation, I shifted to a regimen designed to tackle both the inflammatory and bacterial components more aggressively: 1️⃣ Erythromycin Lotion (Topical Antibiotic): Targets Cutibacterium acnes, the bacteria contributing to acne inflammation. 2️⃣ Adapalene (Topical Retinoid): Acts as a comedolytic and anti-inflammatory to prevent new lesions and reduce existing ones. 3️⃣ Doxycycline (Oral Antibiotic): Provides systemic anti-inflammatory and antibacterial effects, ideal for moderate-to-severe acne. 🧴 Supportive Measures: To minimize side effects and improve adherence, I emphasized: Moisturization: To combat dryness from adapalene. 📊 The Plan Ahead Acne management requires patience and precision. While I expect significant improvement within 4–8 weeks, the key is consistent follow-up to track progress, adjust therapy as needed, and address any concerns. 🔬 This case reinforces the importance of balancing clinical experience with evidence-based decisions. Treatment isn’t one-size-fits-all—what works for one patient may need adjustment for another. 📝 Takeaway: In dermatology, flexibility, patient communication, and a holistic approach are essential for successful outcomes. Remember, treating acne isn’t just about clearing skin—it’s about restoring confidence and improving quality of life. #Dermatology #AcneTreatment #ClinicalPractice #Adapalene #Erythromycin #Doxycycline #PatientCare #HolisticHealth #LinkedInLearning

Great to see Johnson & Johnson embracing #diversity in advertising #tremfya, as there is a high prevalence of #psoriasis in black and hispanic communities, yet 93% of people in #psoriasis commercials are white. What we now need to see is diversity in trials, as only 14% of participants in phase 3 studies are people of color, and fewer than 20% of images in dermatology textbooks show #psoriasis on darker skin. Johnson & Johnson has taken steps against underrepresentation, having launched a study in 2022 dedicated to people of color living with #plaquepsoriasis and scalp #psoriasis, with the sole intent to address gaps in representation.